Alert icon

To align with industry best practices for security and data integrity, Project Data Sphere is requiring users to upgrade their browsers to one that supports encryption protocol TLS 1.2 by December 15, 2017. On that date, Project Data Sphere will disable support of browsers that permit SSL 3.0/TLS 1.0. To prevent any disruption to your access to Project Data Sphere, you must take action.
This browser was not recognized and may not be compatible with TLS 1.2 or higher. Please check with the browser's developer to confirm.
To view information about this, please visit the FAQ. If you have any further questions, please contact us.

Back to the List
Type(s) of Cancer
Breast Cancer
Study Phase
Phase 3
Study Completion Date
April 2012
NCT00041119Uploaded 12-31-2021
Access via NCI by Request
PDS UID: nci-data-486
Cyclophosphamide And Doxorubicin (CA) (4 VS 6 Cycles) Versus Paclitaxel (4 VS 6 Cycles) As Adjuvant Therapy For Breast Cancer in Women With 0-3 Positive Axillary Lymph Nodes:A 2X2 Factorial Phase III Randomized Study
Files: NCT00041119-D1
Data DictionaryNCT00041119-D1-Data-Dictionary_0.pdf
DATANCT00041119-D1-Dataset_0.csv
OTHERREADME.pdf
Files: NCT00041119-D2
Data DictionaryNCT00041119-D2-Data-Dictionary_0.pdf
DATANCT00041119-D2-Dataset_0.csv
OTHERREADME.pdf
Files: NCT00041119-D3
Data DictionaryNCT00041119-D3-Data-Dictionary_0.pdf
DATANCT00041119-D3-Dataset_0.csv
OTHERREADME.pdf
Files: NCT00041119-D4
Data DictionaryNCT00041119-D4-Data-Dictionary_0.pdf
DATANCT00041119-D4-Dataset_0.csv
OTHERREADME.pdf